Back
Altimmune 10K Form
Sell
32
ALT
Altimmune
Last Price:
$5.90
Seasonality Move:
-9.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALT News And Ratings
See the #1 stock for the next 7 days that we like better than ALT
ALT Financial Statistics
Sales & Book Value
| Annual Sales: | $20K |
|---|---|
| Cash Flow: | $-18.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.71 |
| Price / Book: | 3.68 |
Profitability
| EPS (TTM): | -1.34000 |
|---|---|
| Net Income (TTM): | $-95.1M |
| Gross Margin: | $17.9M |
| Return on Equity: | -61.21% |
| Return on Assets: | -55.3% |
Altimmune Earnings Forecast
Key Altimmune Financial Ratios
-
The Gross Profit Margin over the past 9 years for ALT is 99.99%.
-
The Selling, General & Administrative Expenses for ALT have been equal to 104,830.00% of Gross Profit Margin.
-
The Research & Development expenses have been 411,130.00% of Revenue.
-
The Net Earning history of ALT is -475,295.00% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 12 years.
Altimmune Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ALT |
| CUSIP: | 02155H |
| Website: | altimmune.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.11 |
| Quick Ratio: | 12.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |